Argus Investors Counsel’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-7,118
| Closed | -$661K | – | 93 |
|
|
2021
Q1 | $661K | Sell |
7,118
-735
| -9% | -$68.3K | 0.27% | 69 |
|
|
2020
Q4 | $704K | Buy |
7,853
+223
| +3% | +$20K | 0.31% | 64 |
|
|
2020
Q3 | $788K | Sell |
7,630
-3,338
| -30% | -$345K | 0.33% | 58 |
|
|
2020
Q2 | $867K | Buy |
10,968
+1,790
| +20% | +$141K | 0.42% | 52 |
|
|
2020
Q1 | $531K | Buy |
+9,178
| New | +$531K | 0.32% | 48 |
|